Ipca Laboratories Shows Strong Short-Term Gains Amid Mixed Long-Term Performance

Ipca Laboratories has shown notable activity today, gaining 3.07% as of April 22, 2025. The stock has outperformed its sector by 2.64%, marking a consecutive gain over the last two days with a total return of 4.84% during this period. The stock reached an intraday high of Rs 1,474.7, reflecting a rise of 3.77%.
In terms of moving averages, Ipca Laboratories is currently above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below its 100-day moving average. Over the past week, the stock has delivered a performance of 7.98%, compared to the Sensex's 3.88%.

Looking at longer-term performance, Ipca Laboratories has achieved a 10.54% increase over the past year, outpacing the Sensex's 8.23%. However, year-to-date, the stock is down 13.16%, while the Sensex has gained 2.01%. Over three years, Ipca Laboratories has risen by 42.97%, slightly ahead of the Sensex's 39.36% increase. In the five-year span, the stock has appreciated by 88.28%, though this lags behind the Sensex's 154.02% growth.